Direct-Acting Antivirals in Chronic Hepatitis C Genotype 4 Infection in Community Care Setting

BACKGROUND: Limited data exists comparing the safety, tolerability, and efficacy of direct-acting antivirals (DAAs) in patients with chronic hepatitis C genotype 4 (HCV GT-4) in the community practice setting. We aim to evaluate the treatment response of DAAs in these patients. METHODS: All the HCV...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Gastroenterology Res
Autors principals: Gayam, Vijay, Khalid, Mazin, Mandal, Amrendra Kumar, Hussain, Muhammad Rajib, Mukhtar, Osama, Gill, Arshpal, Garlapati, Pavani, Shrestha, Binav, Guss, Debra, Sherigar, Jagannath, Mansour, Mohammed, Mohanty, Smruti
Format: Artigo
Idioma:Inglês
Publicat: Elmer Press 2018
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5916637/
https://ncbi.nlm.nih.gov/pubmed/29707080
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14740/gr999w
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars